Overview

Efficacy and Safety of Tetrabenazine in Chorea

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The primary objective of this study was to establish the absolute reduction of chorea in participants with Huntington's disease(HD) treated with tetrabenazine or placebo

Phase:

Phase 3

Details

Lead Sponsor:

Prestwick Pharmaceuticals

Treatments:

Tetrabenazine